Drug Profile
VE 13045
Alternative Names: Caspase 1 inhibitor VE-13,045 - Vertex; VE-13,045 (irreversible peptidyl ICE inhibitor) - VertexLatest Information Update: 19 May 2011
Price :
$50
*
At a glance
- Originator Vertex Pharmaceuticals
- Class Antirheumatics
- Mechanism of Action Caspase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 19 May 2011 Discontinued - Preclinical for Rheumatic disorders in France (unspecified route)
- 19 May 2011 Discontinued - Preclinical for Rheumatic disorders in USA (unspecified route)
- 25 Feb 1999 No-Development-Reported for Rheumatic disorders in USA (Unknown route)